Anavex Life Sciences
AVXL
AVXL
93 hedge funds and large institutions have $75.6M invested in Anavex Life Sciences in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.18% less ownership
Funds ownership: 21.08% → 20.89% (-0.18%)
41% less call options, than puts
Call options by funds: $1.54M | Put options by funds: $2.59M
Holders
93
Holding in Top 10
1
Calls
$1.54M
Puts
$2.59M
Top Buyers
| 1 | +$4.21M | |
| 2 | +$1.21M | |
| 3 | +$864K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$718K |
| 5 |
Renaissance Technologies
New York
|
+$341K |
Top Sellers
| 1 | -$883K | |
| 2 | -$799K | |
| 3 | -$256K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$251K |
| 5 |
Jane Street
New York
|
-$238K |